Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-31 @ 11:50 AM
Study NCT ID:
NCT04234594
Status:
UNKNOWN
Last Update Posted:
2020-05-19
First Post:
2020-01-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-16
First Submit QC Date:
None
Study First Post Date:
2020-01-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-17
Last Update Post Date:
2020-05-19
Last Update Post Date Type:
ACTUAL